Balyasny Asset Management’s Healthcare Services Acquisition Corporation Warrant HCARW Stock Holding History

Balyasny Asset Management’s Portfolio HCARW Stock Details HCARW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-138,952	Closed	-$4K	–	3428
2022 Q3	$4K	Hold	138,952	–	–	﹤0.01%	2737
2022 Q2	$14K	Hold	138,952	–	–	﹤0.01%	2542
2022 Q1	$49K	Hold	138,952	–	–	﹤0.01%	2234
2021 Q4	$72K	Hold	138,952	–	–	﹤0.01%	2018
2021 Q3	$92K	Hold	138,952	–	–	﹤0.01%	1715
2021 Q2	$124K	Hold	138,952	–	–	﹤0.01%	1778
2021 Q1	$86K	Buy	+138,952	New	+$171K	﹤0.01%	1647

Balyasny Asset Management's HCARW Position: Q4 2022 in Review

Balyasny Asset Management sold out of Healthcare Services Acquisition Corporation Warrant (HCARW) in Q4 2022, closing a stake of 138,952 shares — an estimated $4K sold.

Balyasny Asset Management first reported a position in HCARW in Q1 2021 and held it in 7 quarters. The position peaked at $124K in Q2 2021. 0 funds tracked by Wall St. Rank hold HCARW as of Q4 2022.

Balyasny Asset Management reported no remaining Healthcare Services Acquisition Corporation Warrant position as of Q4 2022 after selling out during the quarter.
Balyasny Asset Management sold 138,952 Healthcare Services Acquisition Corporation Warrant shares in Q4 2022, an estimated $4K.
Balyasny Asset Management first reported a position in Healthcare Services Acquisition Corporation Warrant in Q1 2021 and held it in 7 quarters.
Balyasny Asset Management's Healthcare Services Acquisition Corporation Warrant position peaked at $124K in Q2 2021.
0 funds tracked by Wall St. Rank held Healthcare Services Acquisition Corporation Warrant as of Q4 2022.

Based on Balyasny Asset Management's 13F filing for Q4 2022, filed 14 Feb 2023.